Dolomite Bio announced the launch of a game-changing Nadia single cell platform, a groundbreaking system set to escalate scRNA-Seq to new heights, offering the fast-growing single cell research sector an innovative solution for a wide range of potential applications
The Nadia instrument is a touchscreen-controlled, droplet-based microfluidic platform for single cell research, combining superior microfluidics, automated temperature control and gentle cell/bead agitation to offer a single compact instrument that delivers precise and reliable results.
This novel product family will be on display from 9–10 November 2017 at the 5th Annual Single Cell Analysis Congress (Booth 14) in London, UK, at the Oz Single Cells 2017 in Melbourne, Australia and at the 3rd Annual Boston Understand Your Genome (UYG) Conference in Cambridge, USA, on 14 November.
One, two, four or eight samples can be run in parallel, generating up to 6000 high quality, single cell libraries per sample in approximately 15 minutes.
Configuration with the Nadia Innovate protocol development platform transforms the system into a scalable, open system for the creation of new procedures and applications.
Users can alter parameters — such as droplet size and frequency, temperature, agitation and timings — and optimise protocols with the aid of real-time visualisation, enabling straightforward development of new single cell protocols and applications.
Mike Hawes, CEO of Dolomite Bio, said: “We are excited to be launching the Nadia product family at conferences across three continents. This novel system represents a huge leap forward for single cell research and we look forward to showcasing its capabilities.”